Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
NCT00222378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129
Last updated 2015-07-30
Summary
An increase prevalence of CMV, EBV and or HHV-6 in diseased tissue of inflammatory bowel disease would suggest a role for these viruses in the etiology and/or exacerbation of IBD, whereas their absence would preclude such association.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of Miami
lead OTHER
Principal Investigators
-
Jeffrey B Raskin, M.D. · University of Miami
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-04-30
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- United States
Study Locations
More Related Trials
-
OPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity
NCT07240181 ·Status: NOT_YET_RECRUITING
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Mucosal Gene Expression Defects in IBD
NCT00639821 ·Status: COMPLETED
-
Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis
NCT06228352 ·Status: NOT_YET_RECRUITING
-
Microbial and Human Determinants of the Onset of IBD Flares
NCT05463900 ·Status: ACTIVE_NOT_RECRUITING
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study
NCT05452187 ·Status: COMPLETED
-
Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
NCT01860963 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Inflammatory Bowel Disease in Patients With Perianal Disease
NCT00972088 ·Status: COMPLETED ·Phase: NA
-
Cytomegalovirus Infection in Steroid-refractory Ulcerative Colitis
NCT03467841 ·Status: UNKNOWN
-
Remote Monitoring of IBD
NCT05886322 ·Status: UNKNOWN
-
The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease
NCT05652491 ·Status: WITHDRAWN
-
Crohn's Disease - Inflammation and Microbial Proteolytic Activity
NCT06503081 ·Status: COMPLETED
-
Screening for Hepatitis Virus B Protein X (HBx) in Colitis-associated Cancer (CAC)
NCT06833021 ·Status: NOT_YET_RECRUITING
-
Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases
NCT03841045 ·Status: UNKNOWN
-
Oral Microbiota Dysbiosis in IBD
NCT06980818 ·Status: ACTIVE_NOT_RECRUITING
-
Regulation of Mucosal Healing in Inflammatory Bowel Disease
NCT04504136 ·Status: RECRUITING ·Phase: NA
-
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
NCT06453720 ·Status: RECRUITING
-
Inflammatory Bowel Disease (IBD) and Covid-19 Infection
NCT04492267 ·Status: UNKNOWN
-
Intestinal Microbiome and Chronic Inflammatory Bowel Disease
NCT02768038 ·Status: WITHDRAWN
-
Predictive Value of pCLE Findings in Pediatric IBD
NCT02003859 ·Status: COMPLETED
-
Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy
NCT07089771 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
NCT01364896 ·Status: COMPLETED
-
Differences in Human Germinal Center B Cell Selection Revealed by Analysis of IgVH Gene Hypermutation and Lineage Trees in Inflammatory Bowel Disease
NCT00291681 ·Status: UNKNOWN
-
Anal Dysplasia in Patients With Inflammatory Bowel Disease
NCT01653054 ·Status: COMPLETED ·Phase: NA